About Amrita Therapeutics
Amrita Therapeutics is a company based in Ahmedabad (India) by Tony Fred. It operates as a B2B. Amrita Therapeutics has raised $572.93 thousand across 3 funding rounds from investors including Gujarat Venture Finance, Department of Biotechnology and Ananda Chakrabarty. Amrita Therapeutics offers products and services including Antibodies, Therapeutics, Diagnostic Tools, and Custom Services. Amrita Therapeutics operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Ahmedabad, India
- Founders Tony Fred
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Amrita Therapeutics Limited
- Date of Incorporation 25 Feb, 2008
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$572.93 K (USD)
in 3 rounds
-
Latest Funding Round
$172.93 K (USD), Seed
Feb 15, 2015
-
Investors
Gujarat Venture Finance
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Amrita Therapeutics
Amrita Therapeutics offers a comprehensive portfolio of products and services, including Antibodies, Therapeutics, Diagnostic Tools, and Custom Services.
Various antibodies for research and diagnostics applications
Developments targeting diseases through antibody-based treatments
Kits for detecting infections and diseases in labs or clinics
Tailored antibody and assay development for client needs
Funding Insights of Amrita Therapeutics
Amrita Therapeutics has successfully raised a total of $572.93K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $172.93 thousand completed in February 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Amrita Therapeutics
Amrita Therapeutics has secured backing from 3 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include Gujarat Venture Finance, Department of Biotechnology and Ananda Chakrabarty.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are made in Indian startups across multiple sectors.
|
Locked | Locked | Locked | |
|
Biotechnology research, guidelines, and funding by the Government of India.
|
Locked | Locked | Locked | |
|
AC
Ananda Chakrabarty |
-
|
Locked | Locked | Locked |
Investor details for Amrita Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Amrita Therapeutics
Investment portfolio details for Amrita Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Amrita Therapeutics
Detailed financials for Amrita Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amrita Therapeutics Comparisons
Peer comparison for Amrita Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Amrita Therapeutics
Amrita Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| Locked | Locked | Locked |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
Cancer therapies are developed using selective pathway inhibitors.
|
Detailed competitors of Amrita Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amrita Therapeutics
Complete news archive for Amrita Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amrita Therapeutics
Amrita Therapeutics is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Tony Fred is the current CEO of Amrita Therapeutics. They have also founded this company.
Amrita Therapeutics is a funded company, having raised a total of $572.93K across 3 funding rounds to date.
Amrita Therapeutics focuses on manufacturing high-quality antibodies, developing biological substances, and creating diagnostic kits for use in laboratories, hospitals, and biotech sectors. They offer services like custom antibody development and protein production, supporting research and clinical applications. Based in Blackpool, United Kingdom, they work with universities, pharmaceutical companies, and public health agencies to enable better diagnostics and treatments through reliable products and innovative tools.
Amrita Therapeutics's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Amrita Therapeutics offers Antibodies, Therapeutics, Diagnostic Tools, and Custom Services.
Amrita Therapeutics has 3 investors. Key investors include Gujarat Venture Finance, Department of Biotechnology, and Ananda Chakrabarty.